Guardant Health share price logo

Guardant Health

NASDAQ: GH

Large Cap

$187.22

+9.42

(+5.30%)

as on

Guardant Health Stock Performance

as on October 6, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $176.37
    $187.69
    downward going graph

    5.80%

    Downside

    0.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $61.00
    $187.69
    downward going graph

    67.42%

    Downside

    0.25%

    Upside

    downward going graph

Guardant Health share price movements today

Previous Close
$177.80
Open
$177.76
Volume
1.3M
Market Cap
$23.9B
Day's Low - High
$176.37 - $187.69
52 Week Low - High
$61.00 - $187.69

Guardant Health Historical Returns

1 Month Return
+ 15.99 %
3 Month Return
+ 10.9 %
1 Year Return
+ 195.39 %
3 Year Return
+ 557.37 %
5 Year Return
+ 76.06 %

Guardant Health Stock Fundamentals & Key Indicators

Check Guardant Health market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.9B

EPS (TTM)

-3.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-50.95

Industry PE ratio

19.82

PEG Ratio

11.55

EBITDA

-411.2M

Revenue (TTM)

1.2B

Profit Margin

65.01%

Return On Equity TTM

211.46%

Guardant Health vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Guardant Health with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Guardant Health image
Guardant Health
StrongBuy$23.9B76.06%-50.9565.01%0.00%
Natera image
Natera
StrongBuy$59.1B283.46%-301.7365.30%0.00%
Agilent image
Agilent
StrongBuy$47.3B11.48%32.9653.73%0.49%
Thermo Fisher image
Thermo Fisher
StrongBuy$242.1B17.57%35.1741.03%0.28%
Danaher image
Danaher
StrongBuy$150.5B-26.41%37.8958.51%0.71%

Stock Returns calculator for Guardant Health Stock including INR - Dollar returns

The Guardant Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Guardant Health investment value today

Current value as on today

₹3,20,602

Returns

₹2,20,602

(+220.6%)

Returns from Guardant Health Stock

₹1,95,393 (+195.39%)

Dollar Impact

₹25,209 (+25.21%)

Analyst Recommendation on Guardant Health Stock

Based on 19 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 19 analysts, 100% of analysts recommend a 'BUY' rating for Guardant Health. Average target price of $197.44

Guardant Health Share Price Target

Get share price movements and forecasts by analysts on Guardant Health.

What analysts predicted

5.18%UPSIDE

Target Price

$197.44

Current Price

$187.22

Analyzed by

19 Analysts

High

$225

Target

$197.44

Low

$180

Guardant Health target price $197.44, a slight upside of 5.18% compared to current price of $187.22. According to 19 analysts rating.

Indian Investors' Interest in Guardant Health Stock

Search interest for Guardant Health Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Guardant Health Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
168
177
191
201
203
232
265
281
301
334
Gross Profit
103
104
116
124
128
150
171
181
196
219
Operating Income
-99
-100
-117
-125
-111
-106
-98
-120
-121
-129
EBITDA
-103
-91
-96
-99
-83
-88
-82
-118
-100
-109
Interest Expense
0
0
0
0
0
0
0
1
1
1
Depreciation
10
10
10
10
10
10
9
10
9
9
Income Before Tax
-114
-102
-107
-110
-94
-99
-92
-130
-111
-119
Income Tax Expense
0
0
0
0
0
0
0
-1
0
0
Net Income
-114
-102
-107
-111
-95
-99
-92
-128
-112
-120
Net Profit Margin
61.25%
59.14%
61.10%
61.55%
63.28%
65.01%
64.71%
64.63%
65.22%
65.39%

Guardant Health Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
49
90
214
286
373
449
563
739
982
Gross Profit
18
47
143
194
250
293
336
449
633
Operating Income
-76
-92
-82
-254
-411
-544
-564
-443
-437
EBITDA
-75
-75
-54
-225
-359
-614
-433
-390
-373
Interest Expense
2
1
1
4
2
2
2
2
3
Depreciation
5
7
13
16
22
35
42
42
39
Income Before Tax
-83
-84
-69
-245
-384
-653
-478
-435
-417
Income Tax Expense
0
0
-1
0
0
1
0
1
-1
Net Income
-83
-85
-75
-253
-405
-654
-479
-436
-416
Net Profit Margin
36.56%
52.33%
67.01%
67.73%
67.11%
65.23%
59.74%
60.79%
64.46%

Guardant Health Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-114
-102
-107
-111
-95
-99
-92
-128
-112
-120
Operating Cash Flow
-30
-94
-51
-64
-62
-60
-35
-26
-65
-57
Investing Cash Flow
28
-5
-294
10
302
-10
-14
-905
699
101
Financing Cash Flow
-1
5
-2
-2
-66
1
4
732
-21
23
Change in Cash
-4
-94
-346
-58
174
-68
-45
-200
612
66

Guardant Health Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-83
-84
-67
-246
-384
-654
-479
-436
-416
Operating Cash Flow
-72
-72
-47
-103
-209
-309
-324
-239
-184
Investing Cash Flow
-170
-153
-317
-617
-63
149
840
-261
-627
Financing Cash Flow
281
293
367
1,410
-66
-189
477
0
671
Change in Cash
39
67
2
689
-340
-350
991
-503
-140

Global Institutional Holdings in Guardant Health

Check out the Institutions with significant holdings in Guardant Health.

Funds
Holdings
Vanguard
8.02%
VANGUARD INDEX FUNDS
7.36%
iShares
2.38%
VANGUARD WORLD FUND
2.18%
MUTUAL FUND SERIES TRUST
1.74%
See all

Guardant Health News & Key Events

  • img

    Today's Timeline - 16 September

    Wed, 10:30 PM

    -

    Guardant Health reports Q2 revenues of $335 million, exceeding expectations by 6.4% and raising full-year guidance.

    Thu, 01:30 AM

    -

    Director Steve E. Krognes plans to sell 6,674 shares for $1.17M under Rule 144.

    Thu, 01:33 AM

    -

    Director Musa Tariq plans to sell 116 shares valued at $20,300 under Rule 144.

Insights on Guardant Health

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, GH stock has moved up by 16.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 18 quarters, 96.09M → 334.97M (in $), with an average increase of 7.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GH has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 877.4% return, outperforming this stock by 320.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -112.07M → -120.14M (in $), with an average decrease of 7.2% per quarter

About Guardant Health

Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-genomic liquid biopsy dataset derived from advanced cancer patients. Innovation is a key focus, with the company currently developing the LUNAR-2 test, designed for the early detection of colorectal cancer in eligible asymptomatic individuals. Another emerging solution in development is GuardantConnect, an integrated software platform intended to link biopharmaceutical and clinical clients by connecting patients whose Guardant360 tests reveal actionable alterations with potentially relevant clinical trials. Furthermore, Guardant Health offers the Guardant Reveal Test, which aids in selecting neoadjuvant and adjuvant treatments for early-stage cancer patients. Its portfolio also includes a Guardant360 product for tissue genotyping and Guardant-19 for novel coronavirus detection. The company extends its expertise to biopharmaceutical companies and medical institutions through various development services, encompassing companion diagnostic development, regulatory approval support, clinical study management (including setup, monitoring, and maintenance), testing development, and kit fulfillment.
OrganisationGuardant Health
Headquarters3100 Hanover Street, Palo Alto, CA, 94304, US
IndustryMedical - Diagnostics & Research
CEOHelmy Eltoukhy

Key Management of Guardant Health

Name

Title

Zarak Khurshid

Vice President of Investor Relations

Ms. Gulshan Shaver J.D.

Senior VP of Legal Affairs & Chief Compliance Officer

Ms. Jennifer Higgins

Senior Vice President of Public Affairs

Dr. Helmy Eltoukhy Ph.D.

Co-Founder, Co-CEO & Chairman

Mr. John G. Saia J.D.

Chief Legal Officer & Corporate Secretary

Mr. Andy Ament

Senior Vice President of Operations

Mr. Kumud Kalia

Chief Information Officer

Dr. AmirAli Talasaz Ph.D.

Co-CEO & Director

Mr. Michael Bell

Chief Financial Officer

Dr. Darya Chudova

Chief Technology Officer

FAQs

What is Guardant Health share price today?

Guardant Health share price today is $187.22 as on at the close of the market. Guardant Health share today touched a day high of $187.69 and a low of $176.37.

What is the 52 week high and 52 week low for Guardant Health share?

Guardant Health share touched a 52 week high of $187.69 on and a 52 week low of $61.00 on . Guardant Health stock price today i.e. is closed at $187.22,which is 0.25% down from its 52 week high and 206.92% up from its 52 week low.

What is Guardant Health's market capitalisation today?

Guardant Health market capitalisation is $0.02T as on .

How to invest in Guardant Health Stock (GH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Guardant Health on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Guardant Health Stock (GH) from India?

Indian investors can start investing in Guardant Health (GH) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Guardant Health stock (as per the Rupee-Dollar exchange rate as on ). Based on Guardant Health share’s latest price of $187.22 as on October 6, 2026 at 8:45 am IST, you will get 0.0534 shares of Guardant Health. Learn more about fractional shares .

What are the returns that Guardant Health has given to Indian investors in the last 5 years?

Guardant Health stock has given 76.06% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?